For instance, Nrf2 is activated in astrocytes in Parkinson’s disease [52], while in Alzheimer’s disease it is activated in astrocytes, neurons, and possibly microglia [53]. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.